EUVIMEDEUVIMED entdecken
Systematische Übersicht

Alpelisib for TEK ‐ and PIK3CA ‐Related Venous Malformations: A Systematic Review

Julie Phan iD, Christopher Tran, Shweta Srinivasa, Deshan F Sebaratnam

Australasian Journal of Dermatology · 2026-11 · 67 (7)

DOI: 10.1111/ajd.70178 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Australasian Journal of Dermatology, online erschienen am 05.07.2026. Verfasst von Julie Phan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia. Hauptthemen laut MEDLINE: Class I Phosphatidylinositol 3-Kinases, Vascular Malformations, Thiazoles, Phosphoinositide-3 Kinase Inhibitors. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The phosphoinositide 3‐kinase alpha inhibitor alpelisib has been increasingly used in the treatment of venous malformations. In this systematic review of 47 patients with a molecular diagnosis for their venous malformations treated with alpelisib, a partial or complete radiological response was achieved by 77% of evaluable patients and symptomatic improvement in 98%. Adverse effects were predominantly mild, with hyperglycaemia the most frequent, occurring in 58% of patients with available safety data. Trial Registration PROSPERO Registration: CRD420261339549

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Class I Phosphatidylinositol 3-KinasesVascular MalformationsThiazolesPhosphoinositide-3 Kinase InhibitorsHumans

Stichwörter der Autor:innen

PIK3CA‐related overgrowth spectrumalpelisibphosphatidylinositol 3‐kinasessystematic reviewtargeted therapyvascular malformationsvenous malformations

Substanzen

Class I Phosphatidylinositol 3-KinasesPIK3CA protein, humanThiazolesAlpelisibPhosphoinositide-3 Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia.
  • School of Clinical Medicine, University of New South Wales Medicine and Health, Sydney, New South Wales, Australia.
  • Westmead Hospital, Westmead, New South Wales, Australia.
  • Familial Cancer Service, Crown Princess Mary Cancer Centre Westmead, Westmead Hospital, Westmead, New South Wales, Australia.
  • Hereditary Cancer Clinic, Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia.
  • University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Julie Phan

Zitieren

APA

Phan, J., Tran, C., Srinivasa, S., & Sebaratnam, D. F. (2026). Alpelisib for TEK ‐ and PIK3CA ‐Related Venous Malformations: A Systematic Review. Australasian Journal of Dermatology, 67(7). https://doi.org/10.1111/ajd.70178

Vancouver

Phan J, Tran C, Srinivasa S, Sebaratnam DF. Alpelisib for TEK ‐ and PIK3CA ‐Related Venous Malformations: A Systematic Review. Australasian Journal of Dermatology. 2026;67(7). doi:10.1111/ajd.70178

BibTeX
@article{Phan2026,
  author = {Phan, Julie and Tran, Christopher and Srinivasa, Shweta and Sebaratnam, Deshan F},
  title = {Alpelisib for TEK ‐ and PIK3CA ‐Related Venous Malformations: A Systematic Review},
  journal = {Australasian Journal of Dermatology},
  year = {2026},
  volume = {67},
  number = {7},
  doi = {10.1111/ajd.70178}
}
Kostenlos starten →